The safety and efficacy of acute subcutaneous administration of semaglutide in non-diabetic patients with acute ischemic stroke: a multicentre, phase 2, prospective, randomized, open-label, blinded endpoint trial (ASSET)
RecruitingCTIS2022-501072-25-02
Aarhus University HospitalIschemic Stroke
Start: 2023-04-12Target: 380Updated: 2023-06-20